1. Impact of a hidradenitis suppurativa patient decision aid on treatment decision making: A randomized controlled trial
- Author
-
Donna McLean, Tanja Samardzic, Robert P. Dellavalle, Olivia McBride, Mia Sisic, and Jerry Tan
- Subjects
medicine.medical_specialty ,business.industry ,shared decision making ,hidradenitis suppurativa ,Dermatology ,Decisional conflict ,medicine.disease ,decisional conflict ,law.invention ,CI, confidence interval ,Randomized controlled trial ,Clinical evidence ,law ,patient decision aid ,randomized controlled trial ,Physical therapy ,Decision aids ,Medicine ,Generalizability theory ,Hidradenitis suppurativa ,Original Article ,Treatment decision making ,patient knowledge ,business ,SD, standard deviation - Abstract
Background Patient decision aids are tools that facilitate shared decision making when clinical evidence and patient values and preferences inform the process. Evidence-based guidelines have been developed for clinicians in hidradenitis suppurativa management. To address treatment decision-making needs of hidradenitis suppurativa patients, we developed a hidradenitis suppurativa patient decision aid. Objective To assess the efficacy of the hidradenitis suppurativa patient decision aid during treatment decision making. Methods An online, participant-blinded, parallel-group, randomized controlled trial of the hidradenitis suppurativa patient decision aid versus Mayo Clinic hidradenitis suppurativa website content (Mayo) was conducted with hidradenitis suppurativa patients. Outcomes were knowledge, decisional conflict, and preparation for decision making. Results Forty participants fulfilled inclusion criteria and were randomized to hidradenitis suppurativa patient decision aid or Mayo. In the hidradenitis suppurativa patient decision aid group, data from 16 and 15 participants were analyzed at phases 1 and 2, respectively. In the Mayo group, data from 15 and 13 participants were analyzed at phases 1 and 2, respectively. Increased knowledge (P
- Published
- 2020